Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs LHCOX overlap: 47% of top holdings shared

Bottom line

How much do PRHSX and LHCOX overlap?

47% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 39.0% of PRHSX's assets and 39.8% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.

PRHSX holds far more positions (279 vs 61), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PRHSXLHCOX
Weight overlap (top 25)47%
Shared holdings10
Weight in shared holdings39.0%39.8%
Total positions27961
Expense ratio0.83%0.68%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings PRHSX and LHCOX have in common

Holding% of PRHSX% of LHCOXOverlap
Eli Lilly & Co14.28%10.40%10.40%
Johnson & Johnson6.63%4.96%4.96%
Unitedhealth Group Inc5.99%5.39%5.39%
Gilead Sciences Inc2.82%3.53%2.82%
Thermo Fisher Scientific Inc2.52%2.31%2.31%
Vertex Pharmaceuticals Inc2.28%2.24%2.24%
Natera Inc1.44%3.60%1.44%
Guardant Health Inc1.23%2.61%1.23%
Cvs Health Corp0.94%3.33%0.94%
Protagonist Therapeutics Inc0.85%1.44%0.85%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Abbvie Inc — 5.10%
  2. Merck & Co. Inc. — 4.01%
  3. Bristol-myers Squibb Co — 2.11%
  4. Abbott Laboratories — 1.89%
  5. Intuitive Surgical Inc — 1.87%
  6. Amgen Inc — 1.82%
  7. Stryker Corp — 1.78%
  8. Elevance Health Inc — 1.53%
  9. Danaher Corp — 1.43%
  10. Cardinal Health Inc — 1.03%
  11. Royalty Pharma Plc- Cl A — 0.97%
  12. Tenet Healthcare Corp — 0.94%
  13. Kymera Therapeutics Inc — 0.89%
  14. Moderna Therapeutics Inc — 0.83%
  15. Brightspring Health Services — 0.82%

Only in LHCOX

  1. Novartis AG — 4.19%
  2. Galderma Group AG — 2.60%
  3. Cogent Biosciences Inc — 2.27%
  4. 10X Genomics Inc — 2.16%
  5. BeOne Medicines Ltd — 2.06%
  6. Ascendis Pharma A/S — 1.99%
  7. AstraZeneca PLC — 1.97%
  8. Madrigal Pharmaceuticals Inc — 1.91%
  9. Bridgebio Pharma Inc — 1.84%
  10. Edwards Lifesciences Corp — 1.78%
  11. Revolution Medicines Inc — 1.67%
  12. Arrowhead Pharmaceuticals Inc — 1.52%
  13. Dianthus Therapeutics Inc — 1.44%
  14. Adaptive Biotechnologies Corp — 1.42%
  15. Illumina Inc — 1.42%

Asset mix

Asset typePRHSXLHCOX
Stocks96.4%98.2%
Preferred stock3.0%—
Repurchase agreements—1.2%
Cash & short-term funds0.7%0.8%
Bonds0.2%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryPRHSXLHCOX
US92.6%78.5%
CH0.5%8.8%
NL1.0%2.2%
DK0.7%2.0%
GB1.7%2.0%
BE—1.4%
IL0.2%1.2%
JP0.5%1.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do PRHSX and LHCOX overlap?
About 47% by weight. 10 securities appear in both funds' top 25 holdings; they make up 39.0% of PRHSX's assets and 39.8% of LHCOX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PRHSX and LHCOX have in common?
The largest shared holdings are Eli Lilly & Co, Unitedhealth Group Inc, Johnson & Johnson, Gilead Sciences Inc, Thermo Fisher Scientific Inc.
Should I own both PRHSX and LHCOX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PRHSX or LHCOX?
PRHSX is broader, with 279 positions versus 61 for LHCOX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.